220
Participants
Start Date
August 18, 2025
Primary Completion Date
June 30, 2028
Study Completion Date
June 30, 2030
Vonoprazan based ET
Empirical therapy Based on drug history: Levofloxacin sequential therapy or bismuth quadruple therapy (10 or 14 days) or quadruple therapy
Vonoprazan based SGT
Susceptibility testing guided therapy Based onsusceptibility test:Levofloxacin sequential therapy or bismuth quadruple therapy (10 or 14 days) or rifabutin quadruple therapy
National Taiwan University Hospital, Taipei
National Taiwan University Hospital
OTHER